Novogene Enters Korea, Sparking Genome Data Fears
Expansion of a Chinese Genomics Firm in South Korea In June, a China-based genome analysis firm, Novogene, established a wholly owned subsidiary named Novogene Korea, signaling its formal entry into the South Korean market. This move comes as the company, ranked fifth globally in genome sequencing capabilities, aims to expand its reach by offering discounts…